Chemomab Therapeutics Ltd. (CMMB) Capital expenditures 2018–2025
Chemomab Therapeutics Ltd. (CMMB) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$3,000FY2025 · since FY2018: $213,000 → $3,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3,000 | — |
| FY2024 | $0 | -100.0% |
| FY2023 | $3,000 | -95.6% |
| FY2022 | $68,000 | -71.5% |
| FY2021 | $239,000 | +528.9% |
| FY2020 | $38,000 | -60.0% |
| FY2019 | $95,000 | -55.4% |
| FY2018 | $213,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice